Integrating heterogeneous data to facilitate COVID-19 drug repurposing

In the COVID-19 pandemic, drug repositioning has presented itself as an alternative to the time-consuming process of generating new drugs. This review describes a drug repurposing process that is based on a new data-driven approach: we put forward five information paths that associate COVID-19-relat...

Descripción completa

Detalles Bibliográficos
Autores principales: Prieto Santamaría, Lucía, Díaz Uzquiano, Marina, Ugarte Carro, Esther, Ortiz-Roldán, Nieves, Pérez Gallardo, Yuliana, Rodríguez-González, Alejandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2022
Materias:
Post-Screen (Grey)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520166/
https://www.ncbi.nlm.nih.gov/pubmed/34666181
http://dx.doi.org/10.1016/j.drudis.2021.10.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520166/
https://www.ncbi.nlm.nih.gov/pubmed/34666181
http://dx.doi.org/10.1016/j.drudis.2021.10.002

Ejemplares similares